Company news
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Idle Raised Funds
October 29, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Report for Q3 2026
October 21, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
October 20, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
October 19, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 9th Board of Directors
October 19, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Receipt of EU GMP Certificate by Wholly-owned Subsidiary
October 16, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Progress of the Wholly-owned Subsidiary's Participation in the Investment in Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)
October 13, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Election of New Employee Representative Director
October 12, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 8th Board of Directors
September 29, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Implementation Results of Share Repurchase and Share Changes
September 29, 2026
(603456)"Zhejiang Jiuzhou Pharmaceutical Co., Ltd."Announcement on Amendments to the Articles of Association and Other Policies
September 29, 2026
Notice on Convening the 3rd Extraordinary General Meeting in 2026
September 29, 2026
Announcement on Adjustment of Upper Limit of Repurchase Price Following Implementation of Dividend Distribution for the First Half of 2026
September 3, 2026
Announcement on Using Idle Raised Funds for Cash Management
August 18, 2026
Announcement on Repurchasing Shares for Cancellation and Reduction of Registered Capital and Notification to Creditors
August 14, 2026
Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Idle Raised Funds
August 13, 2026
Semi-annual Report for 2026
August 3, 2026
Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds and Continued Cash Management
July 29, 2026
Announcement on Completion of Closure of Certain Special Accounts for Raised Funds from 2020 Non-public Issuance of Shares
July 28, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
July 16, 2026
Announcement on Completion of Industrial and Commercial Change Registration
July 8, 2026
Announcement on Implementation of Canceling Partial Repurchased Shares
July 6, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
July 1, 2026
Announcement on Closing Some Investment Projects Financed by Raised Funds and Using Residual Raised Funds to Permanently Supplement Current Capital
June 30, 2026
Announcement on Progress in Wholly-owned Subsidiary Participating in Investment to Establish Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)
June 25, 2026
Announcement on Obtaining Drug Registration Certificate by the Subsidiary
June 16, 2026
Announcement on Initially Repurchasing Shares through Call Auction and Progress in Repurchased Shares Reaching 1% of Total Share Capital
June 12, 2026
Announcement on Estimated Daily Related Party Transactions in 2026
June 10, 2026
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
June 5, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 4, 2026
Announcement on the Company's Receipt of the Notice of Approval for Marketing Application of Chemical APIs
June 2, 2026
Announcement on Resolutions of the 21st Meeting of the 8th Board of Directors
May 25, 2026
Announcement on Notifying Creditors of Cancellation of Repurchased Shares
May 18, 2026
Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash Management
May 6, 2026
Announcement on Redemption of Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
April 28, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
April 24, 2026
Announcement on Application for Bank Credit with Self-owned Assets
April 23, 2026
Announcement on Receipt of a No-objection Letter from the Shanghai Stock Exchange for the Controlling Shareholder's Issuance of Exchangeable Corporate Bonds
April 15, 2026
Announcement on Obtaining the European CEP Certificate for Chemical Active Pharmaceutical Ingredient
March 25, 2026
Announcement on Obtaining Drug Registration Certificate by the Wholly-owned Subsidiary
March 16, 2026
Announcement on Progress in Opening a Special Settlement Account for Cash Management Products of Raised Funds and Using Temporary Idle Raised Funds for Cash Management
February 6, 2026
Announcement on Wholly-owned Subsidiary Certified as High-tech Enterprise
January 9, 2026
Announcement on Wholly-owned Subsidiary Participating in Investment to Establish Jiaxing Longfeng Venture Capital Partnership (Limited Partnership)
December 22, 2025
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
December 15, 2025
Announcement on Using Idle Raised Funds for Cash Management
December 9, 2025
Announcement on Approval of ANDA Number for Holding Subsidiary by the United States
November 27, 2025
Announcement on Resolutions of the 18th Meeting of the 8th Board of Directors
November 12, 2025
Indicative Announcement on Internal Restructuring of the Ownership Structure at the Level Above the Controlling Shareholder and Persons Acting in Concert, and Resulting Reduction in the Number of Actual Controllers
November 11, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
October 31, 2025
Announcement on Resolutions of the 17th Meeting of the 8th Board of Directors
October 15, 2025